Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by Haidukon Jan 29, 2016 5:23pm
317 Views
Post# 24507373

About “The Interview”…

About “The Interview”…
I was extremely surprised by the “release” of “The Interview” since it was breaking any logical (legal?) communication rules.

There were no reasons for SBM to raise the bet and to communicate through such a channel, with the risk of backfire…

I was wondering in the last days about this subject…
 
I believe (as mentioned by ZukuenftigReicherSack, on wallstreet-online.de) that “The Interview” was just a private discussion, recorded by a german analyst, with a strong Austrian accent (to remain polite) but not dedicated to be released.

Probably due to the “explosive” content of this discussion, this analyst decided to merchandise such an opportunity via his own website… (I doubt about his naivety, but for his knowledge of the web)… The rest of the story is already known.
 
As a matter of fact, the quality of the recorded video (sound), the attitude of the participants, Attila’s over-confident statements,… seem to confirm that Attila was participating to a private discussion and was not aware that the recorded video will be “published”.
 
The good news is that Attila confirmed the advanced stage of the negotiations, the multiple participants and indicated open scenario (Note: I doubt that management might oppose a take-over – if any – even with the remaining options). Having said that, I hardly believe the figures mentioned (but do not exclude them), while assuming they correspond to the management targets (that might be revised afterwards).

Hopefully, the negotiations have not been negatively affected by “The Interview” accident...

The waiting game goes on...

Haiduk

Bullboard Posts